PD-149 Epidermal growth factor receptor (EGFR)-activating mutations(mut) and response to gefitinib in lung adenocarcinomas

Authors :: I. Maestu
P. Valero
Angel Izquierdo
Cristina Queralt
Vicente Alberola
B. Massuti
Carolina Gómez
Jose-Luis Gonzalez-Larriba
Teresa Moran
D. de Castellanos
Source :: Lung Cancer. 49:S110
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: Pulmonary and Respiratory Medicine
Cancer Research
Lung
biology
business.industry
medicine.anatomical_structure
Gefitinib
Oncology
Cancer research
medicine
biology.protein
Growth factor receptor inhibitor
Epidermal growth factor receptor
business
Tyrosine kinase
medicine.drug

Full Text Access

Tools